CHARLES J CASAMENTO
CIK 1117167 · last filed 2026-01-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.06M
Companies
10
Total Filings
143
Lifetime Open-Market Net
-$3.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ETON | Director | 71,920 | $46.66 | $3.36M | $51.4K | 10 | 2026-01-14 |
| RLMD | Director | 21,484 | $5.23 | $112.4K | -$2.11M | 32 | 2025-12-16 |
| GTBP | Director | — | $0.32 | — | $0 | 2 | 2025-09-08 |
| PaxMedica, Inc. (PXMD) Delisted | Director | 2,386 | $0.00 | $1 | $0 | 5 | 2024-03-14 |
| GridAI Technologies Corp. (FWBI) Delisted | Director | 19,937 | $2.96 | $59.0K | -$1.8K | 5 | 2024-01-04 |
| GridAI Technologies Corp. (AZRX) Delisted | Director | 224,996 | $3.45 | $776.2K | $12.7K | 15 | 2021-01-06 |
| ASTX | Director | 0 | $10.14 | $0 | -$476.8K | 10 | 2013-06-17 |
| VIVUS INC (VVUS) Delisted | Director | 2,612 | — | — | -$910.3K | 15 | 2013-04-22 |
| Astex Pharmaceuticals, Inc (SUPG) Delisted | Director | — | — | — | $0 | 6 | 2011-06-16 |
| COR | Director | 30,000 | $319.58 | $9.59M | $7.5K | 5 | 2009-08-24 |
Recent Filings · Page 3 of 15
143 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-14 | PaxMedica, Inc. (PXMD) Delisted | Grant (A) | +14,000 | $0 | EDGAR |
| 2023-03-03 | ETON | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | GridAI Technologies Corp. (FWBI) Delisted | Grant (A) | +84,745 | $0 | EDGAR |
| 2022-12-20 | RLMD | Grant (A) | — | $0 | EDGAR |
| 2022-10-04 | PaxMedica, Inc. (PXMD) Delisted | Grant (A) | +51,583 | $0 | EDGAR |
| 2022-05-26 | RLMD | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | RLMD | Mixed | — | -$510.0K | EDGAR |
| 2022-02-28 | ETON | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | GridAI Technologies Corp. (FWBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-21 | RLMD | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.